Literature DB >> 30485780

Attention Deficit-Hyperactivity Disorder and Month of School Enrollment.

Timothy J Layton1, Michael L Barnett1, Tanner R Hicks1, Anupam B Jena1.   

Abstract

BACKGROUND: Younger children in a school grade cohort may be more likely to receive a diagnosis of attention deficit-hyperactivity disorder (ADHD) than their older peers because of age-based variation in behavior that may be attributed to ADHD rather than to the younger age of the children. Most U.S. states have arbitrary age cutoffs for entry into public school. Therefore, within the same grade, children with birthdays close to the cutoff date can differ in age by nearly 1 year.
METHODS: We used data from 2007 through 2015 from a large insurance database to compare the rate of ADHD diagnosis among children born in August with that among children born in September in states with and states without the requirement that children be 5 years old by September 1 for enrollment in kindergarten. ADHD diagnosis was determined on the basis of diagnosis codes from the International Classification of Diseases, 9th Revision. We also used prescription records to compare ADHD treatment between children born in August and children born in September in states with and states without the cutoff date of September 1.
RESULTS: The study population included 407,846 children in all U.S. states who were born in the period from 2007 through 2009 and were followed through December 2015. The rate of claims-based ADHD diagnosis among children in states with a September 1 cutoff was 85.1 per 10,000 children (309 cases among 36,319 children; 95% confidence interval [CI], 75.6 to 94.2) among those born in August and 63.6 per 10,000 children (225 cases among 35,353 children; 95% CI, 55.4 to 71.9) among those born in September, an absolute difference of 21.5 per 10,000 children (95% CI, 8.8 to 34.0); the corresponding difference in states without the September 1 cutoff was 8.9 per 10,000 children (95% CI, -14.9 to 20.8). The rate of ADHD treatment was 52.9 per 10,000 children (192 of 36,319 children; 95% CI, 45.4 to 60.3) among those born in August and 40.4 per 10,000 children (143 of 35,353 children; 95% CI, 33.8 to 47.1) among those born in September, an absolute difference of 12.5 per 10,000 children (95% CI, 2.43 to 22.4). These differences were not observed for other month-to-month comparisons, nor were they observed in states with non-September cutoff dates for starting kindergarten. In addition, in states with a September 1 cutoff, no significant differences between August-born and September-born children were observed in rates of asthma, diabetes, or obesity.
CONCLUSIONS: Rates of diagnosis and treatment of ADHD are higher among children born in August than among children born in September in states with a September 1 cutoff for kindergarten entry. (Funded by the National Institutes of Health.).

Entities:  

Mesh:

Year:  2018        PMID: 30485780      PMCID: PMC6322209          DOI: 10.1056/NEJMoa1806828

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  Birth Month and Influenza Vaccination in Children.

Authors:  Christopher Worsham; Jaemin Woo; Anupam B Jena
Journal:  N Engl J Med       Date:  2020-07-09       Impact factor: 91.245

2.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors:  Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

3.  Associations of Birth Factors and Socio-Economic Status with Indicators of Early Emotional Development and Mental Health in Childhood: A Population-Based Linkage Study.

Authors:  Martin Guhn; Scott D Emerson; Dorri Mahdaviani; Anne M Gadermann
Journal:  Child Psychiatry Hum Dev       Date:  2020-02

Review 4.  Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Kim Boesen; Asger Sand Paludan-Müller; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

5.  Moving Upstream to Improve Children's Mental Health Through Community and Policy Change.

Authors:  Alex R Dopp; Paula M Lantz
Journal:  Adm Policy Ment Health       Date:  2020-09

6.  Combined association of BTEX and material hardship on ADHD-suggestive behaviours among a nationally representative sample of US children.

Authors:  Kayla Dellefratte; Jeanette A Stingone; Luz Claudio
Journal:  Paediatr Perinat Epidemiol       Date:  2019-10-27       Impact factor: 3.980

7.  Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children.

Authors:  Gal Shoval; Elina Visoki; Tyler M Moore; Grace E DiDomenico; Stirling T Argabright; Nicholas J Huffnagle; Aaron F Alexander-Bloch; Rebecca Waller; Luke Keele; Tami D Benton; Raquel E Gur; Ran Barzilay
Journal:  JAMA Netw Open       Date:  2021-06-01

Review 8.  2021 Update on Pediatric Overuse.

Authors:  Nathan M Money; Alan R Schroeder; Ricardo A Quinonez; Timmy Ho; Jennifer R Marin; Elizabeth R Wolf; Daniel J Morgan; Sanket S Dhruva; Eric R Coon
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 7.124

9.  Environmental pollution is associated with increased risk of psychiatric disorders in the US and Denmark.

Authors:  Atif Khan; Oleguer Plana-Ripoll; Sussie Antonsen; Jørgen Brandt; Camilla Geels; Hannah Landecker; Patrick F Sullivan; Carsten Bøcker Pedersen; Andrey Rzhetsky
Journal:  PLoS Biol       Date:  2019-08-20       Impact factor: 8.029

10.  Adverse Events And Emergency Department Opioid Prescriptions In Adolescents.

Authors:  Christopher M Worsham; Jaemin Woo; Anupam B Jena; Michael L Barnett
Journal:  Health Aff (Millwood)       Date:  2021-06       Impact factor: 9.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.